Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00136214 · ClinicalTrials.gov registry record
Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 22
- Enrollment target
NCT00136214 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 22 participants.
The verdict
NCT00136214 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The hypothesis of this study is that pegylated interferon would cause cognitive deficits and mood changes in hepatitis C (HCV) positive subjects.
Interventions
- DIAGNOSTIC_TEST MR brain and neuropsychiatric tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2004-03 |
| Est. Completion | 2008-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00136214
The ClinicalTrials.gov registry entry for NCT00136214 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MR brain and neuropsychiatric tests is the first listed.
NCT00136214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00136214 about?
NCT00136214 is a clinical study titled "Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects". The hypothesis of this study is that pegylated interferon would cause cognitive deficits and mood changes in hepatitis C (HCV) positive subjects.
What is the current status of trial NCT00136214?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2004-03. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00136214?
The interventions under investigation include: MR brain and neuropsychiatric tests (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00136214?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.